A Case of Exercise-Induced Acute Renal Failure in a Patient with Idiopathic Renal Hypouricemia Developed during Antihypertensive Therapy with Losartan and Trichlormethiazide.

  • ITO Osamu
    Department of Internal Medicine, Yamagata City Hospital Saiseikan
  • HASEGAWA Yutaka
    Department of Internal Medicine, Yamagata City Hospital Saiseikan
  • SATO Kazuto
    Department of Internal Medicine, Yamagata City Hospital Saiseikan
  • MITSUI Hideaki
    Department of Radiology, Yamagata City Hospital Saiseikan
  • YUDA Fumiaki
    Department of Pathology, Yamagata City Hospital Saiseikan
  • SATO Hiroshi
    Department of Nephrology, Endocrinology and Hypertension, Tohoku University School of Medicine
  • ITO Sadayoshi
    Department of Nephrology, Endocrinology and Hypertension, Tohoku University School of Medicine
  • KUDO Ken-ichi
    Department of Internal Medicine, Yamagata City Hospital Saiseikan

この論文をさがす

抄録

Exercise-induced acute renal failure (ARF) developed in a 45-year-old man during antihypertensive therapy with losartan and trichlormethiazide. The antihypertensive therapy was stopped and marked hypouricemia became apparent during improvement of his renal function. The daily urinary excretion of uric acid was normal and an increased fractional excretion of uric acid was observed. Renal biopsy revealed that the kidney was recovering from acute tubular necrosis with interstitial fibrosis. Based on the results of pyrazinamide and benzbromarone tests, we classified this case as one of presecretory reabsorption defect of uric acid. Antihypertesive therapy with benidipine and candesartan was initiated, and the patient has not had any ARF episodes since. Because idiopathic renal hypouricemia can be associated with exercise-induced ARF and chronic renal dysfunction, careful antihypertensive therapy and follow-up evaluation of renal function might be necessary for hypertensive patients with idiopathic renal hypouricemia. (Hypertens Res 2003; 26: 509-513)

収録刊行物

被引用文献 (3)*注記

もっと見る

参考文献 (34)*注記

もっと見る

詳細情報 詳細情報について

問題の指摘

ページトップへ